• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床药物遗传学检测与应用:韩国检验医学学会2024年更新指南

Clinical Pharmacogenetic Testing and Application: 2024 Updated Guidelines by the Korean Society for Laboratory Medicine.

作者信息

Rim John Hoon, Kim Young-Gon, Kim Sollip, Choi Rihwa, Lee Jee-Soo, Park Seungman, Lee Woochang, Song Eun Young, Lee Soo-Youn, Chun Sail

机构信息

Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Lab Med. 2025 Mar 1;45(2):121-132. doi: 10.3343/alm.2024.0572. Epub 2024 Dec 17.

DOI:10.3343/alm.2024.0572
PMID:39681357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11788703/
Abstract

In the era of precision medicine, pharmacogenetics has substantial potential for addressing inter-individual variability in drug responses. Although pharmacogenetics has been a research focus for many years, resulting in the establishment of several formal guidelines, its clinical implementation remains limited to several gene-drug combinations in most countries, including Korea. The main causes of delayed implementation are technical challenges in genotyping and knowledge gaps among healthcare providers; therefore, clinical laboratories play a critical role in the timely implementation of pharmacogenetics. This paper presents an update of the Clinical Pharmacogenetic Testing and Application guidelines issued by the Korean Society for Laboratory Medicine and aims to provide the necessary information for clinical laboratories planning to implement or expand their pharmacogenetic testing. Current knowledge regarding nomenclature, gene-drug relationships, genotyping technologies, testing strategies, methods for clinically relevant information delivery, QC, and reimbursements has been curated and described in this guideline.

摘要

在精准医学时代,药物遗传学在解决个体间药物反应差异方面具有巨大潜力。尽管药物遗传学多年来一直是研究重点,并已制定了多项正式指南,但在包括韩国在内的大多数国家,其临床应用仍局限于几种基因-药物组合。实施延迟的主要原因是基因分型的技术挑战以及医疗服务提供者之间的知识差距;因此,临床实验室在药物遗传学的及时应用中起着关键作用。本文介绍了韩国检验医学学会发布的《临床药物遗传学检测与应用指南》的更新内容,旨在为计划实施或扩大其药物遗传学检测的临床实验室提供必要信息。本指南整理并描述了有关命名法、基因-药物关系、基因分型技术、检测策略、临床相关信息传递方法、质量控制和报销的当前知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11788703/1ef8b63da1ac/alm-45-2-121-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11788703/1ef8b63da1ac/alm-45-2-121-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11788703/1ef8b63da1ac/alm-45-2-121-f1.jpg

相似文献

1
Clinical Pharmacogenetic Testing and Application: 2024 Updated Guidelines by the Korean Society for Laboratory Medicine.临床药物遗传学检测与应用:韩国检验医学学会2024年更新指南
Ann Lab Med. 2025 Mar 1;45(2):121-132. doi: 10.3343/alm.2024.0572. Epub 2024 Dec 17.
2
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.美国临床实践指南中的药物遗传学检测推荐建议。
Am J Health Syst Pharm. 2024 Aug 12;81(16):672-683. doi: 10.1093/ajhp/zxae110.
3
Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.解读与实施临床药物遗传学检测:服务提供者的观点
Clin Pharmacol Ther. 2019 Aug;106(2):298-301. doi: 10.1002/cpt.1494. Epub 2019 Jun 4.
4
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.DPYD基因分型建议:分子病理学协会、美国医学遗传学与基因组学学会、临床药物基因组学实施联盟、美国病理学家学会、荷兰皇家药剂师协会荷兰药物基因组学工作组、欧洲药物基因组学与个性化治疗学会、药物基因组学知识库以及药物基因变异联盟的联合共识建议
J Mol Diagn. 2024 Oct;26(10):851-863. doi: 10.1016/j.jmoldx.2024.05.015. Epub 2024 Jul 18.
5
[How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].[如何基于药物遗传学信息进行个体化药物治疗?已发表指南的系统评价]
Dtsch Med Wochenschr. 2016 Oct;141(21):e183-e202. doi: 10.1055/s-0042-100973. Epub 2016 Oct 17.
6
[Pharmacogenetics in daily practice].[日常实践中的药物遗传学]
Ned Tijdschr Geneeskd. 2020 Jun 4;164:D4191.
7
Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.临床药物遗传学检测与应用:检验医学临床实践指南
Ann Lab Med. 2017 Mar;37(2):180-193. doi: 10.3343/alm.2017.37.2.180.
8
Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.推动医疗保健领域的精准医学:应对实施挑战以增加临床环境中的药物遗传学检测。
Physiol Genomics. 2017 Jul 1;49(7):346-354. doi: 10.1152/physiolgenomics.00029.2017. Epub 2017 May 26.
9
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.药物基因组学全球研究网络实施工作组:全球合作推进药物基因组学实施。
Pharmacogenet Genomics. 2025 Jan 1;35(1):1-11. doi: 10.1097/FPC.0000000000000547. Epub 2024 Oct 3.
10
Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.标准化可加速药物基因组学的应用:现状与未来之路
Pharmacogenomics. 2018 Jul 1;19(10):847-860. doi: 10.2217/pgs-2018-0028. Epub 2018 Jun 19.

本文引用的文献

1
Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea.基于韩国全国队列数据的预先基因分型获益估计。
Clin Transl Sci. 2024 Mar;17(3):e13772. doi: 10.1111/cts.13772.
2
A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care.关于预防药物不良反应的预先药物基因组学检测的真实世界证据的综述:未来医疗保健的现实。
Pharmacogenomics J. 2024 Mar 15;24(2):9. doi: 10.1038/s41397-024-00326-1.
3
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting.
临床中实施药物基因组学检测对真实世界抗血小板治疗的影响。
Eur J Hum Genet. 2024 Aug;32(8):895-902. doi: 10.1038/s41431-024-01567-1. Epub 2024 Feb 29.
4
Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.大规模生物库中不同生物地理群体的药物基因组等位基因频率。
Am J Hum Genet. 2023 Oct 5;110(10):1628-1647. doi: 10.1016/j.ajhg.2023.09.001. Epub 2023 Sep 26.
5
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting.关于CYP2D6结构变异检测的PharmVar教程及报告建议。
Clin Pharmacol Ther. 2023 Dec;114(6):1220-1237. doi: 10.1002/cpt.3044. Epub 2023 Sep 28.
6
Characterization of complex structural variation in the gene loci using single-molecule long-read sequencing.使用单分子长读长测序对基因位点的复杂结构变异进行表征。
Front Pharmacol. 2023 Jun 22;14:1195778. doi: 10.3389/fphar.2023.1195778. eCollection 2023.
7
The PREPARE study: benefits of pharmacogenetic testing are unclear.PREPARE研究:药物遗传学检测的益处尚不清楚。
Lancet. 2023 Jun 3;401(10391):1850. doi: 10.1016/S0140-6736(23)00853-X.
8
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.临床药物遗传学实施联盟(CPIC)CYP2D6、CYP2C19、CYP2B6、SLC6A4 和 HTR2A 基因型及 5-羟色胺再摄取抑制剂类抗抑郁药指南
Clin Pharmacol Ther. 2023 Jul;114(1):51-68. doi: 10.1002/cpt.2903. Epub 2023 May 30.
9
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.荷兰药物基因组学工作组(DPWG)关于CYP2D6、CYP3A4和CYP1A2与抗精神病药物之间基因-药物相互作用的指南。
Eur J Hum Genet. 2024 Mar;32(3):278-285. doi: 10.1038/s41431-023-01347-3. Epub 2023 Mar 31.
10
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.一个 12 基因药物遗传学检测面板以预防药物不良反应:一项开放标签、多中心、对照、集群随机交叉实施研究。
Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4.